IGM Biosciences, Inc. (IGMS) Financials

IGMS Assets vs Liabilities

DateAssetsLiabilities
2024-03-31 376.1 million 214.9 million
2023-12-31 423.4 million 220.2 million
2023-09-30 474.4 million 220.5 million
2023-06-30 480.7 million 222.1 million

IGMS Free Cash Flow and Stock based compensation

Graph available only for supporters. Become a supporter to see it.
DateFree Cash FlowStock based compensation
2024-03-31 -44.9 million 7.9 million
2023-12-31 -49.5 million 9.2 million
2023-09-30 -43.2 million 12.0 million
2023-06-30 -57.0 million 14.3 million

IGMS Net Income

No data available :(

IGMS Cash and Debt

Graph available only for supporters. Become a supporter to see it.
DateCashDebtCapital Lease
2024-03-31 294.1 million - 40.9 million
2023-12-31 338.3 million - 40.5 million
2023-09-30 387.0 million - 41.2 million
2023-06-30 386.9 million - 41.4 million

IGMS Shares Outstanding

Graph available only for supporters. Become a supporter to see it.
DateShares Outstanding
2024-03-31 60.1 million
2023-12-31 59.8 million
2023-09-30 59.6 million
2023-06-30 45.1 million

IGMS Expenses

Graph available only for supporters. Become a supporter to see it.
DateCapexR&DG&AS&M
2024-03-31 2.5 million 43.8 million 10.5 million -
2023-12-31 1.4 million 52.0 million 11.6 million -
2023-09-30 3.1 million 54.8 million 12.5 million -
2023-06-30 3.9 million 55.7 million 13.0 million -

IGMS Cost of Revenue

Graph available only for supporters. Become a supporter to see it.
DateRevenueCost of Revenue
2024-03-31 497000 2.2 million
2023-12-31 651000 2.2 million
2023-09-30 509000 2.3 million
2023-06-30 448000 3.5 million

IGMS

Price: $8.27

52 week price:
3.81
17.70

Earnings Per Share: -4.71 USD

P/E Ratio: -2.96

Exchange: NMS

Sector: Healthcare

Industry: Biotechnology

Volume: 224815

Market Capitalization: 545.4 million

Links: